Bank of New York Mellon Corp Grows Holdings in Aemetis, Inc. (NASDAQ:AMTX)

Bank of New York Mellon Corp grew its stake in shares of Aemetis, Inc. (NASDAQ:AMTX) by 29.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 91,880 shares of the specialty chemicals company’s stock after purchasing an additional 20,961 shares during the quarter. Bank of New York Mellon Corp’s holdings in Aemetis were worth $247,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in AMTX. Clear Harbor Asset Management LLC purchased a new stake in Aemetis in the 4th quarter valued at about $44,000. FMR LLC raised its stake in shares of Aemetis by 68.2% during the third quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock valued at $52,000 after acquiring an additional 9,137 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Aemetis in the fourth quarter valued at approximately $87,000. Barclays PLC grew its stake in Aemetis by 274.6% in the third quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after purchasing an additional 34,816 shares in the last quarter. Finally, Wellington Management Group LLP purchased a new position in Aemetis during the 3rd quarter worth $177,000. 27.02% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Ascendiant Capital Markets increased their price target on Aemetis from $18.00 to $19.00 and gave the stock a “buy” rating in a research report on Monday, March 17th. HC Wainwright reiterated a “buy” rating and set a $28.00 target price on shares of Aemetis in a report on Friday, March 14th. Finally, StockNews.com upgraded shares of Aemetis to a “sell” rating in a report on Wednesday, February 5th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Aemetis presently has a consensus rating of “Hold” and an average target price of $14.56.

Aemetis Price Performance

Shares of NASDAQ AMTX opened at $1.84 on Friday. Aemetis, Inc. has a 1-year low of $1.50 and a 1-year high of $6.14. The business has a fifty day moving average price of $2.01 and a 200 day moving average price of $2.65. The stock has a market capitalization of $98.11 million, a P/E ratio of -0.81 and a beta of 1.48.

Aemetis Company Profile

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.